Biography:
Susumu Hama, Ph.D., is an Assistant Professor at the Faculty of Pharmaceutical Sciences, Musashino University, Japan. He earned his Ph.D. from Hokkaido University. His research focuses on developing pathological environment-responsive nanoparticles for cancer therapy. He notably pioneered strategies to overcome the "PEG dilemma" using pH-responsive, charge-inverting peptides. Currently, Dr. Hama is advancing the design of multifunctional lipid-based carriers modified with novel devices to achieve both prolonged systemic circulation and efficient intracellular delivery. His work aims to bridge the gap between fundamental pharmaceutical science and clinical oncology.
Title : Overcoming the PEG dilemma via tris-Based surface engineering for acidic microenvironment-responsive tumor-specific uptake and Intracellular delivery